Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2025Antimicrobial Agents and ChemotherapyOpen Access

Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum

View Full Paper
Ask AI
Bookmark
Share

Authors

VNVella NikolovaUniversitätsmedizin GöttingenKLKaren LinnemannstönsUniversitätsmedizin GöttingenAZAnastasiia Zahoruiko

Discussion

Loading...

Member takes

Implication

In vitro analysis shows RSL3 enhances the anti-malarial effect of Pyrimethamine in malaria, indicating novel treatment avenues.

Key Points

  • RSL3 combined with Pyrimethamine significantly inhibits the proliferation of Plasmodium falciparum in red blood cells, suggesting enhanced anti-malarial effects.
  • The study identifies a synergistic effect between RSL3 and Pyrimethamine, particularly with respect to dihydrofolate reductase inhibition in parasites.
  • Assessment utilized various inhibitors to compare effects on parasite growth; only RSL3 with Pyrimethamine had a notable impact on reducing P. falciparum.
  • These findings may contribute to developing new therapeutic strategies against malaria, especially in combatting drug resistance.

Cite This Study

Nikolova et al. (2025) studied this question.

synapsesocial.com/papers/68af431bad7bf08b1ead18d4https://doi.org/10.1128/aac.00471-25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1THE TOXICITY OF POISONS APPLIED JOINTLY11939 · 2,514 citations
  2. 2Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin2022 · 27 citations
  3. 3A Helical Membrane‐Binding Domain Targets the Toxoplasma ROP2 Family to the Parasitophorous Vacuole2009 · 93 citations
  4. 4Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil1997 · 523 citations